Mark Hooper has stepped down as chief financial officer (CFO) at PaperlinX and will also retire as a Director of the company, both effective by September 16. He will assume the position of managing director and chief executive officer of Sigma Pharmaceuticals.
Commenting on the resignation, Tom Park, managing director of PaperlinX says, “Mark has made a strong contribution to PaperlinX as both CFO and as a director of the company.
“It is with regret that we see him leave, but he leaves us with strengthened management across our finance community, and improved processes to help with the future growth of PaperlinX. This platform will help with a smooth transition. I wish Mark well for the future.”
PaperlinX outlines that Hooper’s replacement is yet to be determined.